Adagio Therapeutics (ADGI)
NASDAQ:ADGI
US Market
Holding ADGI?
Track your performance easily

Adagio Therapeutics (ADGI) Financial Statements

0 Followers

Adagio Therapeutics Financial Overview

Adagio Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Adagio Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -51.75M$ -100.74M$ -83.09M$ -56.42M$ -42.19M
EBITDA$ -51.61M$ -100.66M$ -83.09M$ -56.42M$ -42.19M
Net Income Common Stockholders$ -50.99M$ -100.67M$ -83.04M$ -60.38M$ -44.67M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 91.25M$ 392.51M$ 474.88M$ 532.22M$ 591.42M
Total Assets$ 484.61M$ 556.27M$ 620.09M$ 686.27M$ 397.99M
Total Debt$ 1.66M$ 2.86M$ 0.00$ 0.00$ 0.00
Net Debt$ -89.59M$ -389.65M$ -474.88M$ -532.22M$ -591.42M
Total Liabilities$ 69.77M$ 96.88M$ 62.07M$ 53.06M$ 542.62M
Stockholders Equity$ 414.84M$ 459.39M$ 558.02M$ 633.21M$ -144.62M
Cash Flow-
Free Cash Flow$ -57.41M$ -59.05M$ -73.30M$ -54.21M$ -33.57M
Operating Cash Flow$ -57.39M$ -59.05M$ -73.21M$ -54.21M$ -33.57M
Investing Cash Flow$ -17.00K$ 49.00M$ 137.92M--
Financing Cash Flow$ 74.00K$ 45.00K$ -749.00K$ 328.60M$ 334.83M
Currency in USD

Adagio Therapeutics Earnings and Revenue History

Adagio Therapeutics Debt to Assets

Adagio Therapeutics Cash Flow

Adagio Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis